Xgeva
Payments companies reported to CMS as associated with Xgeva. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xgeva, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xgeva
These are the largest totals companies reported as associated with Xgeva. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Henshaw | Washington, DC | Orthopaedic Surgery | $11,036.03 |
| Matthew Ehrhardt | Memphis, TN | Pediatric Hematology-Oncology | $9,970.45 |
| Jose Lozada Costas | San Juan, PR | Hematology & Oncology | $3,231.35 |
| Dana Thompson | Nashville, TN | Medical Oncology | $1,975.88 |
| Edgardo Santos | Fort Lauderdale, FL | Hematology & Oncology | $1,025.71 |
| Leroy Keiser | Santa Rosa, CA | Hematology & Oncology | $681.92 |
| Alison Stopeck | Tucson, AZ | Hematology & Oncology | $649.00 |
| Armando Garcia | Rio Piedras, PR | Hematology & Oncology | $614.95 |
| Carlos Mendez Serrano | Caguas, PR | Hematology & Oncology | $589.40 |
| Luis Baez Vallecillo | San Juan, PR | Hematology & Oncology | $538.03 |
Prescribed Xgeva?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.